Mankind Pharma has launched a Rs 3,000 crore QIP to fund its acquisition of Bharat Serums and Vaccines. The company has seen ...

Mumbai: The National Green Tribunal (NGT) has dismissed allegations of water pollution against the Ambernath plant of Bharat ...

The pharma company has acquired 100% stake in BSV for ₹13,768 crore, to be funded through a combination of internal accruals ...

The QIP opened on December 16, 2024, with Mankind Pharma keeping the option to offer a discount of up to 5% on the floor ...

Mankind Pharma, India’s fourth-largest pharmaceutical company by domestic sales, has officially launched its Rs 3,000 crore ...

In a meeting held on December 20, 2024, the Fund Raising Committee of the company had approved the issue of 1.19 crore equity ...

The proposed capital raise is part of Mankind Pharma's plan to fund the Rs 13,630-crore acquisition of private equity firm ...

Advent International has been present in India since 2007 and has committed over $6 billion in that time, spread across 19 ...

The indicative issue price for the QIP is expected to be approximately ₹2,520 per share, which could lead to an equity ...